Trentino Innovation AEVA Biotech Srl
AEVA develops diagnostic tools for the analysis of the extracellular vesicles - that is to say nanoparticles released by cells into biological fluids - with the aim of detecting biomarkers in liquid biopsies of cancer patients and monitoring how the tumor evolves and responds to therapies.
Subscribe to our newsletter to receive
our news right in your inbox!